Pre-Market Momentum For Stereotaxis (STXS) Following Key Approval
At the recent pre-market check, shares of Stereotaxis, Inc. (NYSE: STXS) rose 3.10% to $2.33, marking a significant uptick on the US stock charts. STXS stock finished at $2.26 during the last trading session, marking a noteworthy 10.24% rise. Its groundbreaking robotic medical technology received regulatory approval in China, which is what caused the upward …
Pre-Market Momentum For Stereotaxis (STXS) Following Key Approval Read More »